Condensed Consolidated Statements of Cash Flows (USD $) In Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Reconciliation of net earnings (loss) to cash (used) provided by operating activities
Net earnings (loss)	$ 4,433	$ (17,338)
Add (deduct):
Depreciation and amortization	14,343	16,744
Provision for bad debt	1,250	3,269
Investment and other losses (gains) - net	2,115	(11,932)
Payments for title losses in excess of provisions	(6,501)	(19,907)
Insurance recoveries of title losses	3,210	6,599
(Increase) decrease in receivables - net	(6,626)	41,737
Increase in other assets - net	(566)	(2,534)
Decrease in payables and accrued liabilities - net	(15,622)	(5,743)
Decrease in net deferred income taxes	(2,869)	(158)
Net earnings from equity investees	(1,043)	(1,487)
Dividends received from equity investees	1,889	1,906
Other - net	1,052	3,204
Cash (used) provided by operating activities	(4,935)	14,360
Investing activities:
Proceeds from investments available-for-sale matured and sold	172,783	173,881
Purchases of investments available-for-sale	(170,017)	(140,534)
Proceeds from redemptions of investments - pledged		217,225
Purchases of property and equipment and title plants - net	(13,788)	(9,045)
Increases in notes receivable	(324)	(420)
Collections on notes receivable	650	641
Change in cash and cash equivalents due to sale and deconsolidation of subsidiaries (see below)		(1,873)
Cash paid for the acquisition of subsidiaries and other - net (see below)	(8,262)
Cash paid for loan guarantee obligation	(3,928)
Net cash (paid) received for other assets, cost-basis investments, equity investees and other	(77)	4,654
Cash (used) provided by investing activities	(22,963)	244,529
Financing activities:
Payments on notes payable	(4,688)	(15,806)
Payments on line of credit		(216,141)
Purchase of remaining interest of consolidated subsidiaries		(4,116)
Proceeds from notes payable	6,500	2,834
Distributions to noncontrolling interests	(4,457)	(5,485)
Contributions from noncontrolling interests	13
Cash used by financing activities	(2,632)	(238,714)
Effects of changes in foreign currency exchange rates	(794)	270
(Decrease) increase in cash and cash equivalents	(31,324)	20,445
Cash and cash equivalents at beginning of period	154,490	116,100
Cash and cash equivalents at end of period	123,166	136,545
Supplemental information:
Settlement of wage and hour litigation through issuance of Common Stock	7,582
Settlement of note payable through issuance of Common Stock held in treasury	1,299
Changes in financial statement amounts due to purchase of subsidiary:
Goodwill acquired	9,416
Receivables and other assets acquired	5,767
Liabilities acquired	(3,671)
Debt assumed	(3,250)
Cash paid for the acquisition of subsidiaries and other - net (see below)	8,262
Changes in financial statement amounts due to sale and deconsolidation of subsidiaries:
Note receivable		2,433
Investments in investees, on an equity method basis		5,315
Goodwill		(5,902)
Title plants		(1,048)
Property and equipment, net of accumulated depreciation		(1,564)
Intangible asset, net of amortization		2,928
Other - net		(814)
Liabilities		1,390
Noncontrolling interests		336
Investment and other gains - net		(1,201)
Change in cash and cash equivalents due to sale and deconsolidation of subsidiaries (see below)		$ 1,873